December 13, 2016
A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates across Europe.
December 12, 2016
f policymakers get it right, biosimilars could offer more safe and effective treatment options for patients in the coming years – potentially at lower costs.
December 8, 2016
There’s no way to address America’s prescription drug abuse crisis without balanced pain management, explained the National Institutes of Health’s Linda Porter, PhD, at Tuesday’s Summit on Balanced Pain Management.
December 6, 2016
Polling results from Tennessee cast new light on a trend that’s sparking national concerns: non-medical switching.
December 2, 2016
On the heels of recent research confirming breakthrough drugs’ impact on patients with high cholesterol, the Partnership to Advance Cardiovascular Health has released a quick-draw video exploring obstacles for patient access.
November 29, 2016
Despite being cautioned last year by the Centers for Medicare and Medicaid Services, many states still block patients with hepatitis C from receiving curative treatment.
November 22, 2016
For patients with extremely high cholesterol, the promise of new PCSK9 inhibitors just keeps growing.
November 18, 2016
Chronic obstructive pulmonary disease, or COPD, often exists undiagnosed and goes undertreated.
November 16, 2016
The Food and Drug Administration may not have reached consensus on the suffixes that distinguish biological and biosimilar medications, but physicians are of one mind: Meaningful suffixes matter.
November 11, 2016
Cardiovascular disease cuts across ethnicities and demographics as the leading cause of death in the United States, explains a new white paper from the Institute for Patient Access.
